Citation: | HUANG Zhihuan, LIANG Xiao, GAO Xiangdong, CHEN Song. Effects and mechanisms of SNP-9 on Parkinson''s disease cell model induced by rotenone[J]. Journal of China Pharmaceutical University, 2023, 54(2): 238-244. DOI: 10.11665/j.issn.1000-5048.2023020101 |
[1] |
Panicker N, Kam TI, Wang H, et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson''s disease[J]. Neuron, 2022, 110(15): 2422-2437.e9.
|
[2] |
Mahul-Mellier AL, Burtscher J, Maharjan N, et al. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration[J]. Proc Natl Acad Sci U S A, 2020, 117(9): 4971-4982.
|
[3] |
Davie CA. A review of Parkinson''s disease[J]. Br Med Bull, 2008, 86: 109-127.
|
[4] |
Mantovani S, Smith SS, Gordon R, et al. An overview of sleep and circadian dysfunction in Parkinson''s disease[J]. J Sleep Res, 2018, 27(3):
|
[5] |
Hussein A, Guevara CA, Del Valle P, et al. Non-motor symptoms of Parkinson''s disease: the neurobiology of early psychiatric and cognitive dysfunction[J]. Neuroscientist, 2023, 29(1): 97-116.
|
[6] |
Jankovic J,Tan EK. Parkinson''s disease: etiopathogenesis and treatment[J]. J Neurol Neurosurg Psychiatry, 2020, 91(8): 795-808.
|
[7] |
Bloem BR, Okun MS, Klein C. Parkinson''s disease[J]. Lancet, 2021, 397(10291): 2284-2303.
|
[8] |
Yao S, Xu Z, Chen S, et al. Silk fibroin hydrolysate improves memory impairment via multi-target function[J]. J Funct Foods, 2022, 89: 104942.
|
[9] |
Xu Z, Chen S, Wang Y, et al. Neuroprotective effects of silk fibroin hydrolysate against Aβ25–35 induced cytotoxicity in SH-SY5Y cells and primary hippocampal neurons by regulating ROS inactivation of PP2A[J]. J Funct Foods, 2018, 45: 100-109.
|
[10] |
Zaman V, Shields DC, Shams R, et al. Cellular and molecular pathophysiology in the progression of Parkinson''s disease[J]. Metab Brain Dis, 2021, 36(5): 815-827.
|
[11] |
Subramaniam SR, Chesselet MF. Mitochondrial dysfunction and oxidative stress in Parkinson''s disease[J]. Prog Neurobiol, 2013, 106-107: 17-32.
|
[12] |
Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson''s disease[J]. Aging Cell, 2019, 18(6):
|
[13] |
Ott M, Gogvadze V, Orrenius S, et al. Mitochondria, oxidative stress and cell death[J]. Apoptosis, 2007, 12(5): 913-922.
|
[14] |
Rocha SM, Bantle CM, Aboellail T, et al. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice[J]. Neurobiol Dis, 2022, 167: 105685.
|
[15] |
Radad K, Al-Shraim M, Al-Emam A, et al. Rotenone: from modelling to implication in Parkinson''s disease[J]. Folia Neuropathol, 2019, 57(4): 317-326.
|
[16] |
Chen YJ, Gao XD, Chen S. Effects and mechanisms of FGF21 on neuronal damage induced by rotenone[J]. J China Pharm Univ (中国药科大学学报),2020,51(6):718-723.
|
[17] |
Zha Q, Gao XD, Chen S. Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson''s disease[J]. J China Pharm Univ (中国药科大学学报), 2021, 52(3): 346-351.
|
[18] |
Lopes FM, da Motta LL, De Bastiani MA, et al. RA differentiation enhances dopaminergic features, changes redox parameters, and increases dopamine transporter dependency in 6-Hydroxydopamine-induced neurotoxicity in SH-SY5Y cells[J]. Neurotox Res, 2017, 31(4): 545-559.
|
[19] |
Lopes FM, Schr?der R, da Frota ML, Jr., et al. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies[J]. Brain Res, 2010, 1337: 85-94.
|
[20] |
Dionísio PA, Amaral JD, Rodrigues CMP. Oxidative stress and regulated cell death in Parkinson''s disease[J]. Ageing Res Rev, 2021, 67: 101263.
|
[21] |
Wu Y, Chen M, Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling[J]. Mitochondrion, 2019, 49: 35-45.
|
[1] | MENG Yue, YAO Siyuan, GAO Xiangdong, CHEN Song. Effects and mechanisms of SNP-9 on Aβ25-35-induced damage in bEnd.3 cells[J]. Journal of China Pharmaceutical University, 2022, 53(3): 333-339. DOI: 10.11665/j.issn.1000-5048.20220311 |
[2] | CHEN Yingjie, GAO Xiangdong, CHEN Song. Effects and mechanisms of FGF21 on neuronal damage induced by rotenone[J]. Journal of China Pharmaceutical University, 2020, 51(6): 718-723. DOI: 10.11665/j.issn.1000-5048.20200611 |
[3] | LI Wei, XU Xuefen. Mechanism of resveratrol induced apoptosis on human prostate cancer cell line DU145[J]. Journal of China Pharmaceutical University, 2018, 49(6): 711-717. DOI: 10.11665/j.issn.1000-5048.20180612 |
[4] | FENG Quanfu, BI Lei, YAN Xiaojing, YANG Ye, CHEN Weiping. Inhibition of tetramethypyrazine on proliferation of HepG2 cells and its effects on the pathway of mitochondrial apoptosis[J]. Journal of China Pharmaceutical University, 2015, 46(3): 350-354. DOI: 10.11665/j.issn.1000-5048.20150315 |
[5] | QI Cuiling, ZHOU Xinlei, YE Jie, YANG Yang, ZHANG Qianqian, LI Jiangchao, WANG Lijing. Andrographolide induces Tb cell apoptosis by activating Caspase-3/PARP[J]. Journal of China Pharmaceutical University, 2013, 44(6): 559-562. DOI: 10.11665/j.issn.1000-5048.20130614 |
[6] | REN Jie, XIN Wenqun, CHEN Xin, HU Kun. Apoptosis induced by podophyllotoxin derivative OAMDP in HeLa cells[J]. Journal of China Pharmaceutical University, 2013, 44(3): 267-271. DOI: 10.11665/j.issn.1000-5048.20130316 |
[7] | LEI Hui, TAN Jiani, LI Shaoping, LI Haitao, JI Hui. Turmeric oil induces human hepatoma cell apoptosis via mitochondrial pathway[J]. Journal of China Pharmaceutical University, 2013, 44(3): 263-266. DOI: 10.11665/j.issn.1000-5048.20130315 |
[8] | Effects of panaxatriol saponins on the differentiation and apoptosis of MC3T3-E1 cells[J]. Journal of China Pharmaceutical University, 2010, 41(3): 273-377. |
[9] | Mechanism of TNF Related Apoptosis Inducing Ligand Inducing Apoptosis and Its Pharmaceutical Exploitation[J]. Journal of China Pharmaceutical University, 2004, (4): 91-94. |
[10] | Effect of Nerve Regeneration Factor on Apoptosis Cells in the Newborn Rat Spinal Cord[J]. Journal of China Pharmaceutical University, 2002, (1): 60-63. |